A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer

Overview of attention for article published in Frontiers in oncology, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 11 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 24,069 followers.

A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer https://t.co/vUQQVivSuh https://t.co/AKnI7wS7Wi

20 Dec 2022

Reply Repost Favourite

New research: A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer: Purpose To compare the pharmacokinetic (PK)… https://t.co/J5WW6Wg3ug

20 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.